Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

PDE5 inhibitors beyond erectile dysfunction.

P Sandner1, J Hütter, H Tinel

  • 1Product-Related Research, Bayer HealthCare, Wuppertal, Germany.

International Journal of Impotence Research
|July 13, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Re: Bobelyak M, Vaculik J, Stepan JJ. Bone mineral density assessment using Radiofrequency Echographic Mult Spectrometry (REMS) in patients before and after total hip replacement, Osteoporos Int 2025;https://doi.org/10.1007/s00198-025-07685-w and Re: Pocock N, Chan D. Editorial: Is REMS-BMD truly a measured parameter? A call for transparency and technical clarification, Osteoporos Int 2025;https://doi.org/10.1007/s00198-025-07699-4.

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·2025
Same author

Characterizing fetoplacental response to acute maternal hyperoxygenation in suspected coarctation of aorta using fetal cardiac MRI.

Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology·2025
Same author

Determination of chlorinated paraffins and olefins in plastic consumer products of the Swiss market.

Chemosphere·2025
Same author

Molecular signatures of cortical expansion in the human foetal brain.

Nature communications·2024
Same author

Networking Aspects of the Electronic Health Records: Hypertext Transfer Protocol Version 2 (HTTP/2) vs HTTP/3.

Journal of medical systems·2024
Same author

Molecular signatures of cortical expansion in the human fetal brain.

bioRxiv : the preprint server for biology·2024
Same journal

Attachment orientation and sexual excitation and inhibition independently predict sexual desire and sexual arousal, but their interaction does not.

International journal of impotence research·2026
Same journal

Comment on: Application of gelatin sponge (Gelfoam®) as a hemostatic agent in inflatable penile prosthesis implantation.

International journal of impotence research·2026
Same journal

It Comes at Night: A Nocturnal Emissions Historical Review.

International journal of impotence research·2026
Same journal

Challenging the paradigm: what is vasculogenic erectile dysfunction?

International journal of impotence research·2026
Same journal

Comment on: GLP-1 receptor agonists and male sexual health: translating cardiometabolic benefits into erectile outcomes.

International journal of impotence research·2026
Same journal

Erectile and ejaculatory outcomes after penile fracture repair: a comparative analysis of absorbable vs non-absorbable sutures.

International journal of impotence research·2026
See all related articles

Phosphodiesterase type-5 (PDE5) inhibitors, commonly used for erectile dysfunction, show promise for new therapeutic uses. Research is exploring their role in modulating cyclic GMP (cGMP) for various conditions.

Area of Science:

  • Pharmacology
  • Molecular Biology
  • Urology

Background:

  • Phosphodiesterase type-5 (PDE5) inhibitors like sildenafil, vardenafil, and tadalafil are established first-line treatments for erectile dysfunction (ED).
  • Over 40 million men have been treated with these drugs since 1998, highlighting their safety and tolerability.
  • The mechanism involves modulating intracellular cyclic GMP (cGMP) signaling pathways.

Purpose of the Study:

  • To review and synthesize existing preclinical and clinical data on PDE5 inhibitors.
  • To critically evaluate the evidence supporting potential new therapeutic indications beyond ED.
  • To explore the physiological functions of PDE5 and its role in cGMP modulation.

Main Methods:

  • Comprehensive literature search of preclinical and clinical studies on PDE5 inhibitors.

Related Experiment Videos

  • Critical analysis of published data regarding efficacy and safety in various conditions.
  • Synthesis of information to identify emerging therapeutic opportunities.

    • Main Results:

    • PDE5 inhibitors have demonstrated success in treating pulmonary hypertension, as exemplified by sildenafil's approval in 2005.
    • Numerous other potential indications are under investigation in preclinical and clinical development.
    • The modulation of cGMP pools by PDE5 inhibitors offers a basis for novel therapeutic strategies.

    Conclusions:

    • PDE5 inhibitors possess a favorable safety profile, making them suitable for exploring broader therapeutic applications.
    • Further research into PDE5's role in cGMP signaling could unlock new treatments for various diseases.
    • This review consolidates current knowledge to guide future research and clinical development of PDE5 inhibitors.